کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
319245 539251 2007 10 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی روانپزشکی بیولوژیکی
پیش نمایش صفحه اول مقاله
Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia outpatients with prominent negative symptoms
چکیده انگلیسی

AimsTo compare olanzapine and risperidone outcome on some neurocognitive dimensions in chronic schizophrenia patients with prominent negative symptoms.MethodWe randomised and followed for 1 year 235 chronic schizophrenia outpatients with a SANS global score ≥ 10 to open-label flexible-dose treatment with olanzapine or risperidone. Clinical, functional and cognitive assessments [including the COGLAB battery reaction time, vigilance-span of apprehension (VSA) and a card-sorting task] were done periodically.ResultsThere were no significant differences between olanzapine (n = 120) and risperidone (n = 115) treatments in the neurocognitive dimensions tested. Mean ± SD doses were 12.2 ± 5.8 mg/day of olanzapine and 4.9 ± 2.0 mg/day of risperidone. Patients in the olanzapine group showed a significant improvement in the VSA total score, but the within-group change was modest (effect size of 0.26); the difference with the risperidone group was not significant (p = 0.207). Patients in both groups showed a significant improvement in a composite measure of executive efficiency based on the card-sorting task, with within-group effect size of 0.21 (risperidone) and 0.35 (olanzapine); the between-group difference was not significant (p = 0.164). At baseline, better functional status correlated with VSA. Patients scoring lower on VSA or executive efficiency at baseline improved more on these respective measures.ConclusionModest pro-cognitive effects can also be found in chronic schizophrenia outpatients with prominent negative symptoms when treated with olanzapine or risperidone.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Neuropsychopharmacology - Volume 17, Issue 11, November 2007, Pages 725–734
نویسندگان
, , , , , ,